By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Would you give one breath if you could detect lung cancer and other diseases?

Introducing OneBreath™

A unique technology platform developed by Breath Diagnostics to quantitatively analyze organic compounds in a single breath to detect lung cancer and other diseases.

Our highly portable system is readily accessible for patients and easy to use for providers.

In contrast to a Low-Dose CT Scan, OneBreath is a quicker and easier way of lung cancer diagnosis. We are currently enrolling patients for our 2nd generation system Pilot Study.

Breath Collection

Patients provide one complete breath via a unique collection system in less than 30 seconds.

Breath Processing and Analysis

In a simple automated process, the OneBreath™ micro-reactor captures the organic compounds contained in the breath. Once captured, the samples is analyzed in our laboratories.

Get Results

Results with be available within 3-4 days.

Why OneBreath™?

OneBreath™ provides a safe, convenient, and inexpensive way to identify lung cancer in at risk patients, before they know they have a problem.

Accurate Results

OneBreath™ detects lung cancer with dramatically fewer false positives and higher specificity than a low-dose CT scan.


The OneBreath™ system greatly increases access to potentially life-saving lung cancer screenings by being portable enough for use in a physicians office or local pharmacy.


The OneBreath™ technology platform demonstrates a significantly lower false positive rate versus CT scans, dramatically reducing the number of unnecessary follow-up diagnostic procedures.

Easy to Use

The simplicity of the OneBreath™ system will dramatically enhance screening compliance due to the fact that only a single breath is required.

News & Publications

New Report: Critically Low Lung Cancer Screening Rates Reveal Opportunity to Save More Lives
American Lung Association’s report examines toll of lung cancer state-by-state, underscores urgent need for more people to be screened
November 15, 2022
Breath Diagnostics, Mayo Clinic Laboratories Announce Collaboration to Develop New Diagnostic Test That Detects Lung Cancer Using Patients’ Exhaled Breath
Breath Diagnostics, Inc. and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases.
March 26, 2019


To the promise of breath based lung cancer diagnostics and what Breath diagnostics could offer patients
"Technology like OneBreath has so much potential for improving and saving lives."
Dr. Kevin Gardner
Executive VP Research and Innovation, University of Louisville
OneBreath™ by Breath Diagnostics

OneBreath™ could save your life.

Contact us to discover the future of lung cancer screening.